AUM Biosciences

About:

AUM Biosciences is committed to addressing the unmet medical needs by developing innovative and affordable oncology therapeutics for Asia.

Website: https://www.aumbiosciences.com/

Top Investors: The Agency for Science, Technology and Research, SPRIM, Everlife

Description:

AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers.

Total Funding Amount:

$28.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Singapore, Central Region, Singapore

Founded Date:

2018-01-01

Founders:

Vishal Doshi

Number of Employees:

11-50

Last Funding Date:

2021-10-12

IPO Status:

Private

Industries:

© 2025 bioDAO.ai